Who Owns Hims & Hers Health Company?

Hims & Hers Health Bundle

Get Full Bundle:

	SWOT	$15	$10
	5 FORCES	$15	$10
	BCG	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10

TOTAL:

ADD TO CART

Who Really Calls the Shots at Hims & Hers?

Unraveling the Hims & Hers Health SWOT Analysis reveals more than just market strategies; it highlights the critical importance of understanding the company's ownership. From its inception as a telehealth innovator to its current status as a publicly traded entity, the evolution of Hims & Hers' ownership structure has profoundly influenced its growth and strategic direction. Knowing who owns Hims & Hers is key to grasping its potential.

Understanding the Hims & Hers ownership is crucial, especially given its impressive financial performance, including a $12.4 billion market capitalization as of June 13, 2025. The journey of Hims & Hers company from a startup to a major player in the telehealth sector is a testament to the impact of its Hims & Hers investors and the evolving dynamics of its shareholder base. This exploration will provide insights into the Hims & Hers parent company and its stakeholders.

The story of Hims & Hers Health, Inc. begins with its founders. Understanding the initial ownership structure and the evolution of its investors provides crucial insights into the company's journey. This section delves into the founders, early backers, and significant shareholders that shaped the company.

Hims & Hers, now a publicly traded company, has a complex ownership structure. The founders and early investors played pivotal roles in shaping the company's trajectory. Their contributions are essential to understanding the company's current position in the market and its future prospects.

Hims & Hers Health, Inc. was established in 2017 by Andrew Dudum, Jack Abraham, and Hilary Coles. Andrew Dudum currently serves as the Co-Founder and Chief Executive Officer, and also holds the position of Chairman of the Board. As of May 15, 2025, Andrew Dudum remains a significant individual shareholder, holding 89,311 shares, representing 5.1% of the company's insider ownership. While the exact equity splits at the company's inception are not publicly available, Dudum's continued significant shareholding underscores his ongoing commitment and influence within the company.

Early Investors and Venture Capital

Early financial backing was crucial for Hims & Hers. These investors provided the capital and strategic support needed to establish and grow the direct-to-consumer telehealth platform. Understanding these early investments is key to grasping the company's development.

• Early investors included McKesson Ventures, Founders Fund, and Institutional Venture Partners (IVP).
• Other venture capital firms that invested in Hims & Hers include Maverick Ventures, UpHonest Capital, and DCM Ventures.
• Maverick Ventures, the private investment arm of Maverick Capital, focuses on early-stage healthcare and technology businesses.
• DCM Ventures is an early-stage venture capital firm concentrating on mobile, consumer internet, communications, and service sectors.

Hims & Hers Health SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

The evolution of Hims & Hers' ownership structure is marked by its transition to a publicly traded company. The company went public on January 20, 2021, via a SPAC merger with Oaktree Acquisition Corp. This strategic move valued the company at $1.6 billion, with shares initially priced at $10. The merger provided $279.5 million in proceeds, which included investments from Franklin Templeton and other Oaktree clients.

Since its IPO, Hims & Hers' market capitalization has significantly increased. As of June 13, 2025, the market cap reached approximately $12.4 billion. This growth reflects the company's expansion and investor confidence in its business model within the telehealth sector. This growth is also a testament to the Growth Strategy of Hims & Hers Health.

The ownership of Hims & Hers is largely held by institutional investors. As of April 2025, institutional investors held approximately 94.68% of the company's shares. Major shareholders include BlackRock, Inc., Vanguard Group Inc, and Goldman Sachs Group Inc. These significant holdings highlight the confidence of institutional investors in Hims & Hers' long-term growth potential. As of May 2025, institutional investors held 72.31% of shares, while mutual funds held 40.46%.

Ownership Insights

Hims & Hers' ownership structure is dominated by institutional investors, reflecting strong market confidence. The company's market capitalization has grown substantially since its IPO, indicating positive investor sentiment and business expansion.

• Institutional investors hold a significant majority of shares.
• Market capitalization has increased to approximately $12.4 billion.
• Major shareholders include BlackRock, Vanguard, and Goldman Sachs.
• The company's evolution showcases its growth in the telehealth market.

Hims & Hers Health PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

The current board of directors of Hims & Hers Health, Inc. oversees the company's operations and strategic direction. According to the company's proxy statement filed on April 25, 2025, the board consists of ten director nominees who will serve until the 2026 annual meeting of stockholders. Andrew Dudum, the co-founder and CEO, also serves as the Director and Chairman of the Board. The board includes a mix of representatives, some of whom may represent major shareholders, alongside independent directors. The company's Board classifications automatically sunset at the 2024 annual meeting, meaning all directors are now elected for one-year terms. This structure ensures that the board remains accountable to the shareholders and can adapt to the evolving needs of the company.

The composition of the board reflects a blend of experience and perspectives, which is crucial for guiding a publicly traded company like Hims & Hers. The board's role includes making key decisions about the company's strategy, financial performance, and risk management. The structure and composition of the board are essential for ensuring effective corporate governance and protecting the interests of all stakeholders. Understanding the board's structure is a key aspect of understanding the Hims & Hers ownership and how the company is governed.

Regarding the voting structure, as of February 21, 2025, Hims & Hers had 213,787,949 shares of Class A common stock and 8,377,623 shares of Class V common stock issued and outstanding. The company has no non-voting stock outstanding. Stockholders of record as of April 14, 2025, were entitled to vote at the annual meeting held on June 12, 2025. The voting structure generally follows a one-share-one-vote principle for Class A common stock, although details on Class V common stock's specific voting rights would typically be outlined in the company's charter documents. SEC filings, such as Form 4, report changes in beneficial ownership for officers and directors, providing insight into their holdings and any transactions, including those made pursuant to Rule 10b5-1 trading plans. Knowing the Hims & Hers investors and their voting power is crucial for understanding the company's direction. For more information on the ideal consumer, check out the Target Market of Hims & Hers Health.

Key Takeaways on Hims & Hers Ownership

The board of directors is crucial for the company's governance and strategic oversight.

• Andrew Dudum, co-founder and CEO, also serves as the Director and Chairman of the Board.
• The company has a dual-class share structure, with Class A and Class V common stock.
• Stockholders of record as of April 14, 2025, were entitled to vote at the annual meeting held on June 12, 2025.
• Understanding the voting structure helps in understanding Who owns Hims.

Hims & Hers Health Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

In the past few years, Hims & Hers Health, Inc. has shown dynamic shifts in its ownership structure. A key move was the repurchase of 2,135,919 shares of Class A common stock for $35.0 million under a 2024 Share Repurchase Program, with the authorization of up to $100.0 million for repurchases, reflecting a strategic approach to capital allocation. Further strengthening its financial position, the company priced an upsized $870.0 million convertible senior notes offering in May 2025, aimed at supporting global expansion and investments in AI and personalized treatments. These actions highlight the company's focus on long-term growth and value creation for its shareholders.

The company's strategic moves include expanding globally, as seen in its agreement to acquire ZAVA, a leading digital health platform in Europe, in a cash-funded deal expected to close in the second half of 2025. This acquisition will broaden the company’s presence in the UK and launch it into Germany, France, and Ireland, underscoring its commitment to international growth. Industry trends in telehealth also show increased institutional ownership and consolidation, which is relevant to understanding the dynamics of Growth Strategy of Hims & Hers Health.

Recent insider transaction reports (Form 4 filings) in May and June 2025 reveal changes in beneficial ownership by company officers and directors. These filings provide transparency into insider activity, which is a key aspect of understanding the ownership dynamics of Hims & Hers. For instance, Michael Chi, Chief Commercial Officer, and Andrew Dudum, have reported transactions, offering insights into the perspectives of key stakeholders. With revenue soaring to $586 million in Q1 2025, up 111% year-over-year, and adjusted EBITDA of $91.1 million, the company's financial performance continues to attract investor interest. Projections for full-year 2025 revenue range from $2.3 billion to $2.4 billion and Adjusted EBITDA from $270 million to $320 million, indicating robust growth.

Hims & Hers Ownership Structure

Hims & Hers is a publicly traded company, which means its ownership is distributed among various shareholders, including institutional investors and the general public. The company's stock performance and investor relations are key factors in understanding its ownership dynamics.

Key Shareholders and Investors

Major shareholders and institutional investors play a significant role in Hims & Hers' ownership. Understanding the identity of these investors provides insight into the company's strategic direction and financial backing. The company's financial backers shape its long-term vision.

Insider Activity and Stock Performance

Insider transactions, as reported in Form 4 filings, offer insights into the perspectives of company officers and directors. Monitoring these activities provides valuable data on the company's financial health and future prospects. Hims & Hers stock ticker symbol is "HIMS."

Financial Performance and Valuation

The company's revenue growth and adjusted EBITDA are key indicators of its financial performance. These metrics influence the company's valuation and attract investor interest. Hims & Hers' market capitalization reflects its overall value in the market.

Hims & Hers Health Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔

Related Blogs